Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Zhang, Meng-Xia; Wang, Li; Zeng, Lei; Tu, Zi-Wei

doi:10.3389/fonc.2021.670714

CORRECTION article

Front. Oncol. , 18 March 2021

Sec. Molecular and Cellular Oncology

Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.670714

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

This article is a correction to:

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
1. Read original article

$\nMeng-Xia Zhang&#x;$ Meng-Xia Zhang¹^†

Li Wang²^†

Lei Zeng³^*

Zi-Wei Tu⁴^*

¹State Key Laboratory of Oncology in South China, Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
²Department of Radiotherapy, Eye & ENT Hospital, Fudan University, Shanghai, China
³Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
⁴NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang University), Nanchang, China

A Corrigendum on
LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

by Zhang, M.-X., Wang, L., Zeng, L., and Tu, Z.-W. (2021). Front. Oncol. 10:605777. doi: 10.3389/fonc.2020.605777

An author name was incorrectly spelled as Lei Zheng. The correct spelling is Lei Zeng.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: nasopharyngeal carcinoma, lipocalin 2, hypoxia-inducible factor 1-alpha, radioresistance, recurrence

Citation: Zhang M-X, Wang L, Zeng L and Tu Z-W (2021) Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma. Front. Oncol. 11:670714. doi: 10.3389/fonc.2021.670714

Received: 22 February 2021; Accepted: 22 February 2021;
Published: 18 March 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Zhang, Wang, Zeng and Tu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zi-Wei Tu, dHV6aXdlaTE5ODgwM0AxNjMuY29t; Lei Zeng, emxzcG9ydHMxMDBAMTYzLmNvbQ==

^†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good